Home/Filings/4/0001415889-21-002616
4//SEC Filing

Walts Alan Edmund 4

Accession 0001415889-21-002616

CIK 0001035354other

Filed

May 19, 8:00 PM ET

Accepted

May 20, 4:11 PM ET

Size

5.8 KB

Accession

0001415889-21-002616

Insider Transaction Report

Form 4
Period: 2021-05-19
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-05-19+3,3343,334 total
    Exercise: $1.48Exp: 2031-05-19Common Stock (3,334 underlying)
Footnotes (1)
  • [F1]The stock option was issued pursuant to the Issuer's 2018 Equity Incentive Plan and vests as follows: one half (1/2) of the shares underlying the option shall vest on May 19, 2022 (the "Cliff Vesting Date"), the remainder of the grant shall vest in twelve (12) equal installments on each successive monthly anniversary of the Cliff Vesting Date, subject to Reporting Person's continuous service as of each such date.

Issuer

Eloxx Pharmaceuticals, Inc.

CIK 0001035354

Entity typeother

Related Parties

1
  • filerCIK 0001853544

Filing Metadata

Form type
4
Filed
May 19, 8:00 PM ET
Accepted
May 20, 4:11 PM ET
Size
5.8 KB